Creo Medical Group - one of the most exciting companies on AIM?
The medical device company focusing on the emerging field of surgical endoscopy has attracted plenty of interest since listing and it certainly looks a really exciting offering, as our Blog here shows....
CREO clearly has a huge opportunity in a multi £billion market. The Group also appears to have made plenty of progress since arriving on AIM in December 2016 at a share price of 76p and market capitalisation of a modest £61m, reflected in the 200% rise in share price to 228p.
- Background
Creo Medical was founded in 2003 as MicroOncology Ltd by the Group’s current Chief Technology Officer, Prof Chris Hancock, initially to target the…
Previous article Next article
